Angio Suites Market size was valued at USD 1245.0 million in 2022 and is expected to grow to USD 2104.20 million by 2030 and grow at a CAGR of 6.78% over the forecast period of 2023-2030.
Multi-purpose exam rooms called Angio suites are used to execute a variety of Angio interventional procedures. Angioplasties, therapeutic stenting, blockage bypasses, intravascular treatment, myelograms, vertebroplasty, and the removal of tissue samples without surgery are among the procedures carried out in these. Angio Suites often have an image intensifier, an X-ray generator, and a rotating table top for simple patient placement and movement. Aortic analysis, complex angiography, stomach aortic aneurysm, and other procedures are all available in angio suites.
KEY DRIVERS:
Growing Healthcare Policies
Technological developments
The capabilities of Angio Suites have been greatly enhanced by ongoing developments in imaging technologies and minimally invasive techniques. Angio Suites' incorporation of cutting-edge imaging technologies, including computed tomography (CT) and magnetic resonance imaging (MRI), has made it possible to precisely and instantly visualize blood arteries, assisting in the diagnosis and treatment of patients.
RESTRAIN:
Accessibility Issues
High Investment
Angio Suites are complex and cutting-edge medical imaging equipment that call for a large financial commitment for acquisition, installation, and upkeep. Smaller healthcare facilities or those operating in areas with low financial resources may find the high cost to be a hindrance.
OPPORTUNITY:
Expanding Treatment Option
Improved Diagnostic Capabilities
Angio suites offer high-resolution imaging features that let medical professionals precisely diagnose and evaluate problems affecting the blood vessels. This enables accurate diagnosis, earlier disease identification, and better treatment planning.
CHALLENGES:
Infection Control
Maintenance and downtime
Angio suites contain sophisticated technology that needs routine upkeep and sporadic repairs. When equipment breaks down, the workflow might be disrupted, and treatments may need to be rescheduled, which could have an impact on patient care and raise costs. As a result, having a solid maintenance strategy and backup systems is crucial.
The COVID-19 pandemic caused a significant restructuring of medical procedures and healthcare services. During the COVID-19 crisis, many countries separated medical treatments based on the necessity for urgent medical attention to expedite the workflow, and numerous medical procedures that were considered elective were suspended. For instance, according to a Center for Health Design Organization report from 2023, the patients were isolated and received care in distinct Angio rooms with ventilation devices to prevent cross-contamination. During the pandemic, most hospitals treated acute cases of emergency including life-threatening conditions such as thrombectomy for stroke, endovascular aortic aneurysm repair for aortic ruptures, non-deferrable oncologic treatments, and organ-saving procedures.
IMPACT OF RUSSIAN UKRAINE WAR
Some indirect effects of the Russian-Ukrainian conflict on the market for Angio are the battle may have caused hospitals and other healthcare facilities to be destroyed or damaged in the impacted areas. As healthcare organizations work to rebuild and restore their operations, this could make it more difficult for people to embrace and use Angio Suites.
Armed conflicts have the potential to lead to economic instability in the affected areas, which could have negative effects including less healthcare spending and less investment in medical technology. In such circumstances, hospitals and healthcare organizations might decide to delay or cut back their intentions to buy pricey equipment like Angio Suites, which would restrict the market's expansion.
IMPACT OF ONGOING RECESSION
Several things can affect the demand for Angio suites during a recession During a recession, hospitals and healthcare providers may experience financial difficulties and healthcare budgets may be cut. A decrease in capital expenditures, including purchases of pricey medical equipment like Angio suites.
During a recession, hospitals and healthcare facilities may postpone or abandon expansion plans or equipment improvements. The demand for Angio suites may be impacted as a result of healthcare providers prioritizing necessary expenses. Economic downturns can put pressure on insurance firms and government healthcare programs to lower reimbursement rates. Lower reimbursement rates might deter healthcare organizations from purchasing pricey equipment, such as Angio suites.
KEY MARKET SEGMENTS
By Product type:
Single plan Angio
Biplane Angio Suits
By End users:
Hospitals
Cath labs
Other
.png)
North America is anticipated to be the market leader for Angio suites. Due to rising investments, technical improvements, and the rising incidence of cardiovascular and other chronic diseases. North America has a strong presence of leading market players, increasing investments in research and developments, and the prevalence of cardiovascular disease.
Asia Pacific is projected to expand at a rapid pace followed by the market in Latin America and the Middle East and Africa. Rise in the focus of the government of countries in Asia on enhancing health care facilities, increasing in the focus of market players in Asia Pacific to leverage growth opportunities rise in the prevalence of cardiovascular diseases.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin American
Siemens, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi Ltd., ESAOTE SPA, IMRIS, Onex Corporation, Canon Inc.,3D Systems Inc., General Electric, Shimadzu Corporation, GIMIAS, FUJIFILM Holdings Corporation, Hologic, Inc., Planmeca, Mindray Medical, International Limited,ZEISS International, Guerbet, Surgical Science, B. Braun and other players listed in the final report.
The successful acquisition of the imaging business "BK Medical" from Boston, Massachusetts, in the United States was announced by GE Healthcare. A payment of USD 1.46 billion from GE has completed the deal. Additionally, the deal has improved GE Healthcare's ultrasound division.
'Bi-Plane Neuro Angio Procedure Suite' with DTAS (Direct to Angio Suite) technology was introduced by Yashoda Hospitals (Secunderabad, India), in honor of World Stroke Day.
| Report Attributes | Details |
| Market Size in 2022 | US$ 1245.0 Mn |
| Market Size by 2030 | US$ 2104.20 Mn |
| CAGR | CAGR of 6.78% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Single plan Angio, Biplane Angio Suits) • By End users (Hospitals, Cath labs, Other) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Siemens, Koninklijke Philips N.V, Lam Vascular and Associates, Hitachi Ltd., ESAOTE SPA, IMRIS, Onex Corporation, Canon Inc.,3D Systems Inc., General Electric, Shimadzu Corporation, GIMIAS, FUJIFILM Holdings Corporation, Hologic, Inc., Planmeca, Mindray Medical, International Limited,ZEISS International, Guerbet, Surgical Science, B. Braun |
| Key Drivers | • Growing Healthcare Policies • Technological developments |
| Market Opportunities | • Expanding Treatment Option • Improved Diagnostic Capabilities |
Ans: The market for Angio Suites Market is anticipated to expand by 6.78% from 2023 to 2030.
Ans: Angio Suites Market size was valued at USD 1245.0 million in 2022.
Ans: North America dominated the market.
Ans: Growing Healthcare Policies and technological developments
Ans: Asia Pacific has the quickest CAGR growth.
Table of Contents
1.Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
4 Impact Analysis
4.1 Impact of COVID-19
4.2 Impact of the Russia-Ukraine War
4.3 Impact of Ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Angio Suites Market Segmentation, By Product Type
8.1 Single plan Angio
8.2 Biplane Angio Suits
9. Angio Suites Market Segmentation, By End Users
9.1 Hospitals
9.2 Cath labs
9.3 Other
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1.1 North America Angio Suites Market by Country
10.2.1.2 North America Angio Suites Market by Product Type
10.2.1.3 North America Angio Suites Market by End Users
10.2.4 USA
10.2.4.1 USA Angio Suites Market by Product Type
10.2.4.2 USA Angio Suites Market by End Users
10.2.5 Canada
10.2.5.1 Canada Angio Suites Market by Product Type
10.2.5.2 Canada Angio Suites Market by End Users
10.2.6 Mexico
10.2.6.1 Mexico Angio Suites Market by Product Type
10.2.6.2 Mexico Angio Suites Market by End Users
10.3 Europe
10.3.1 Europe Angio Suites Market by Country
10.3.2 Europe Angio Suites Market by Product Type
10.3.3 Europe Angio Suites Market by End Users
10.3.4 Germany
10.3.4.1 Germany Angio Suites Market by Product Type
10.3.4.2 Germany Angio Suites Market by End Users
10.3. UK
10.3.5.1 UK Angio Suites Market by Product Type
10.3.5.2 UK Angio Suites Market by End Users
10.3.6 France
10.3.6.1 France Angio Suites Market by Product Type
10.3.6.2 France Angio Suites Market by End Users
10.3.7 Italy
10.3.7.1 Italy Angio Suites Market by Product Type
10.3.7.2 Italy Angio Suites Market by End Users
10.3.8 Spain
10.3.8.1 Spain Angio Suites Market by Product Type
10.3.8.2 Spain Angio Suites Market by End Users
10.3.9 The Netherlands
10.3.9.1 Netherlands Angio Suites Market by Product Type
10.3.9.2 Netherlands Angio Suites Market by End Users
10.3.10 Rest of Europe
10.3.10.1 Rest of Europe Angio Suites Market by Product Type
10.3.10.2 Rest of Europe Angio Suites Market by End Users
10.4 Asia-Pacific
10.4.1 Asia Pacific Angio Suites Market by Country
10.4.2 Asia Pacific Angio Suites Market by Product Type
10.4.3 Asia Pacific Angio Suites Market by End Users
10.4.4 Japan
10.4.4.1 Japan Angio Suites Market by Product Type
10.4.4.2 Japan Angio Suites Market by End Users
10.4.5 South Korea
10.4.5.1 South Korea Angio Suites Market by Product Type
10.4.5.2 South Korea Angio Suites Market by End Users
10.4.6 China
10.4.6.1 China Angio Suites Market by Product Type
10.4.6.2 China Angio Suites Market by End Users
10.4.7 India
10.4.7.1 India Angio Suites Market by Product Type
10.4.7.2 India Angio Suites Market by End Users
10.4.8 Australia
10.4.8.1 Australia Angio Suites Market by Product Type
10.4.8.2 Australia Angio Suites Market by End Users
10.4.9 Rest of Asia-Pacific
10.4.9.1 APAC Angio Suites Market by Product Type
10.4.9.2 APAC Angio Suites Market by End Users
10.5 The Middle East & Africa
10.5.1 The Middle East & Africa Angio Suites Market by Country
10.5.2 The Middle East & Africa Angio Suites Market by Product Type
10.5.3 The Middle East & Africa Angio Suites Market by End Users
10.5.4 Israel
10.5.4.1 Israel Angio Suites Market by Product Type
10.5.4.2 Israel Angio Suites Market by End Users
10.5.5 UAE
10.5.5.1 UAE Angio Suites Market by Product Type
10.5.5.2 UAE Angio Suites Market by End Users
10.5.6 South Africa
10.5.6.1 South Africa Angio Suites Market by Product Type
10.5.6.2 South Africa Angio Suites Market by End Users
10.5.7 Rest of Middle East & Africa
10.5.7.1 Rest of Middle East & Asia Angio Suites Market by Product Type
10.5.7.2 Rest of Middle East & Asia Angio Suites Market by End Users
10.6 Latin America
10.6.1 Latin America Angio Suites Market by Country
10.6.2 Latin America Angio Suites Market by Product Type
10.6.3 Latin America Angio Suites Market by End Users
10.6.4 Brazil
10.6.4.1 Brazil Angio Suites Market by Product Type
10.6.4.2 Brazil Africa Angio Suites Market by End Users
10.6.5 Argentina
10.6.5.1 Argentina Angio Suites Market by Product Type
10.6.5.2 Argentina Angio Suites Market by End Users
10.6.6 Rest of Latin America
10.6.6.1 Rest of Latin America Angio Suites Market by Product Type
10.6.6.2 Rest of Latin America Angio Suites Market by End Users
11. Company Profile
11.1 Siemens
11.1.1 Market Overview
11.1.2 Financials
11.1.3 Product/Services/Offerings
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Koninklijke Philips N.V
11.2.1 Market Overview
11.2.2 Financials
11.2.3 Product/Services/Offerings
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Lam Vascular and Associates
11.3.1 Market Overview
11.3.2 Financials
11.3.3 Product/Services/Offerings
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 Hitachi Ltd.
11.4.1 Market Overview
11.4.2 Financials
11.4.3 Product/Services/Offerings
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 ESAOTE SPA
11.5.1 Market Overview
11.5.2 Financials
11.5.3 Product/Services/Offerings
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 IMRIS
11.6.1 Market Overview
11.6.2 Financials
11.6.3 Product/Services/Offerings
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 Onex Corporation
11.7.1 Market Overview
11.7.2 Financials
11.7.3 Product/Services/Offerings
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 Canon Inc.
11.8.1 Market Overview
11.8.2 Financials
11.8.3 Product/Services/Offerings
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 3D Systems Inc.
11.9.1 Market Overview
11.9.2 Financials
11.9.3 Product/Services/Offerings
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 General Electric
11.10.1 Market Overview
11.10.2 Financials
11.10.3 Product/Services/Offerings
11.10.4 SWOT Analysis
11.10.5 The SNS View
11.11 Shimadzu Corporation
11.11.1 Market Overview
11.11.2 Financials
11.11.3 Product/Services/Offerings
11.11.4 SWOT Analysis
11.11.5 The SNS View
11.12 GIMIAS
11.12.1 Market Overview
11.12.2 Financials
11.12.3 Product/Services/Offerings
11.12.4 SWOT Analysis
11.12.5 The SNS View
11.13 FUJIFILM Holdings Corporation
11.13.1 Market Overview
11.13.2 Financials
11.13.3 Product/Services/Offerings
11.13.4 SWOT Analysis
11.13.5 The SNS View
11.14 Hologic, Inc.
11.14.1 Market Overview
11.14.2 Financials
11.14.3 Product/Services/Offerings
11.14.4 SWOT Analysis
11.14.5 The SNS View
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
13. USE Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Digital Therapeutics (DTx) Market size was estimated at USD 6.30 billion in 2023 and is expected to reach USD 44.13 billion by 2031 at a CAGR of 31.02% during the forecast period of 2024-2031.
The Research Antibodies Market size was estimated USD 1.7 billion in 2022 and is expected to reach USD 2.4 billion by 2030 at a CAGR of 4.9% during the forecast period of 2023-2030.
The Biopreservation Market size was estimated USD 2.2 billion in 2022 and is expected to reach USD 16.2 billion by 2030 at a CAGR of 28.4% during the forecast period of 2023-2030.
The Laboratory Information Management System (LIMS) Market Size was valued at USD 2.05 billion in 2022, and is expected to reach USD 3.69 billion by 2030 and grow at a CAGR of 7.6% over the forecast period 2023-2030.
The Rotator Cuff Injury Treatment Market size was estimated USD 989.3 million in 2022 and is expected to reach USD 1439.5 million by 2030 at a CAGR of 4.8% during the forecast period of 2023-2030.
The Diet Pills Market size is expected to reach USD 3.04 Bn by 2030 and was valued at USD 1.45 Bn in 2022, the CAGR is expected to be 9.7% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
